gracillin has been researched along with Malignant Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, XL; Li, JK; Wang, Y; Yung, KK; Zhang, Z; Zhu, PL | 1 |
| Hu, K; Yao, X | 1 |
2 other study(ies) available for gracillin and Malignant Melanoma
| Article | Year |
|---|---|
Gracillin exerts anti-melanoma effects in vitro and in vivo: role of DNA damage, apoptosis and autophagy.
Topics: Animals; Apoptosis; Autophagy; Cell Line, Tumor; Cell Proliferation; DNA Damage; Melanoma; Mice; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases | 2023 |
The cytotoxicity of methyl protoneogracillin (NSC-698793) and gracillin (NSC-698787), two steroidal saponins from the rhizomes of Dioscorea collettii var. hypoglauca, against human cancer cells in vitro.
Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Central Nervous System Neoplasms; Colonic Neoplasms; Dioscorea; Dose-Response Relationship, Drug; Female; Humans; Kidney Neoplasms; Lethal Dose 50; Leukemia; Male; Melanoma; Mice; Phytotherapy; Plant Extracts; Plant Roots; Prostatic Neoplasms; Saponins; Spirostans; Steroids; Tumor Cells, Cultured | 2003 |